SCHEMBL5376871

SCHEMBL5376871

CCOC(=O)/C=C/c1cn(Cc2ccc(OCc3ccccc3)cc2)nc1OCc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
NR1H4 Q96RI1 1/20 0.44
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 1/20 0.43
GSK3B P49841 1/20 0.43
BACE1 P56817 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PTGS1 P23219 2/20 0.43
PTGS2 P35354 2/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
HSP90AA1 P07900 1/20 0.42
PTPN1 P18031 1/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377143 0.95 MEN1 (0.49) PTGDR2SMN1; SMN2MEN1KMT2AGAA
SCHEMBL5397126 0.89 GAA (0.61) PTGDR2SMN1; SMN2MEN1KMT2ANR1H4
SCHEMBL6593163 0.88 GAA (0.58) PTGDR2SMN1; SMN2MEN1KMT2AGAA
SCHEMBL6593156 0.88 GAA (0.58) PTGDR2SMN1; SMN2MEN1KMT2AGAA
SCHEMBL5380788 0.88 FFAR1 (0.52)
SCHEMBL5381942 0.85 SMN1; SMN2 (0.58) PTGDR2SMN1; SMN2MEN1KMT2AGAA
SCHEMBL5372013 0.82 FFAR1 (0.39) SMN1; SMN2KMT2ALMNAALDH1A1
SCHEMBL5407247 0.82 GAA (0.64) SMN1; SMN2MEN1KMT2AGAALMNA
SCHEMBL5407245 0.82 GAA (0.64) SMN1; SMN2MEN1KMT2AGAALMNA
SCHEMBL5372048 0.81 MEN1 (0.51) PTGDR2MEN1KMT2ANR1H4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 US disclosed